Iframe is blocked. Accept cookies to load it.

By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.

Northern LightBook a Live Demo

Life Sciences & Healthcare

Pharma competitive intelligence from molecule to market.

SinglePoint delivers governed pharma competitive intelligence for life sciences and healthcare: it centralizes trial data, scientific publications, patents, regulatory signals, competitor pipelines and internal research in one governed platform, and cites every claim to its source document. From molecule to market, R&D, competitive intelligence, and medical affairs teams move faster, anticipate shifts, and protect launch readiness.

Book a live demoExplore the platform
Pipeline watchCited to source
  • TrialToday
    Competitor begins a Phase 3 trial in a new indication
    1
    Trial registry
  • LiteratureToday
    Preprint reports mechanism data for a rival compound
    2
    Preprint · Scientific literature
  • RegulatoryYesterday
    Regulator issues draft guidance on accelerated approval
    3
    Regulatory update

Powering strategic insight for the world’s leading life science enterprises

  • Johnson & Johnson
  • Daiichi Sankyo
  • Merck
  • Takeda
  • AbbVie
  • Organon
  • Genmab
  • Alkermes
  • argenx
  • CSL Behring
  • Pfizer
  • Thermo Fisher
  • EMD Serono
  • GSK
  • Humana
  • Bayer
  • Cigna
  • Mayo Clinic

The problem

Friction in insight slows innovation.

In life sciences, every delayed insight, duplicated study, or missed signal increases cost, risk, and lost opportunity.

  1. 01
    Scattered clinical and competitive signals.
    Trial data, regulatory updates, and competitor moves live in separate systems, slowing visibility and response.
  2. 02
    Research redundancy across teams.
    Without a single source of truth, R&D, CI, and medical affairs duplicate effort, wasting budget and delaying impact.
  3. 03
    Manual synthesis burns time.
    Analysts spend hours combing through PDFs and portals instead of interpreting the strategy.
  4. 04
    Insights miss the moment.
    By the time intelligence reaches decision-makers, the opportunity may be gone, putting pipeline strategy and launch readiness at risk.

How SinglePoint helps

One governed source, from molecule to market.

Monitor clinical, scientific and competitive signals

Monitor trial registries, scientific publications, patents, regulatory updates and competitor pipelines in one governed platform, auto curated and mapped to your strategic priorities.

CI summary · Therapeutic area AThis week

Summary

Two competitor assets are advancing toward Phase 3.
1
2

One adds a new indication; the other reports updated safety data.

  • Trial registry
    Phase 2 readout scheduled for a competitor asset
  • Journal article
    Peer-reviewed safety data in the target population
  • Patent
    New composition-of-matter filing by a rival
  • Internal study
    Your prior KOL research on treatment sequencing

Role- and function-specific delivery

Tailor dashboards, alerts, and newsletters for therapeutic teams, R&D, CI, and brand leads, so the right stakeholders get the right signal in time to act.

Enterprise-safe governed AI synthesis

Ask questions in plain language and receive explainable answers cited to the source document, drawn from licensed and internal sources and tuned for regulated life sciences environments.

From signal to decision

Turn life-sciences signals into cited intelligence.

  1. Step 01

    Monitor the sources that shape the market

    SinglePoint brings trial registries, scientific literature, patents, regulatory updates, licensed research and internal intelligence into one governed environment.

  2. Step 02

    Search, synthesize and verify

    Industry-specific enrichment and governed AI surface relevant signals and return answers cited to the source document, so teams can verify what supports the conclusion.

  3. Step 03

    Deliver intelligence to the teams making the decision

    R&D, competitive intelligence, medical affairs and strategy teams use dashboards, alerts, newsletters and cited answers to inform pipeline, launch and market decisions.

Use cases

Pharma competitive intelligence use cases.

  1. Trial and competitor monitoring.

    Track competitor pipelines, clinical study results, and regulatory changes with automated dashboards, cutting hours from manual review.

    Tracks

  2. Scientific literature intelligence.

    Unify peer-reviewed research, preprints, and abstracts across therapeutic areas, delivered in real time to R&D and medical teams.

    Sources

  3. Compliance and risk monitoring.

    Surface policy changes, off-label claims, and risk indicators across global markets to protect launch timelines and brand reputation.

    Surfaces

In their words

“Before SinglePoint, our CI team spent days preparing competitive summaries. Now we deliver daily briefings across therapeutic areas, with confidence, consistency, and zero duplication.”
Director of Competitive Intelligence, top-10 global pharma

Proof

Results from teams like yours.

  • Competitive intelligence

    Launched 150 AI-curated briefings and dashboards across global product lines, eliminating manual overhead.

  • Consumer insights

    Unified global research and delivered precision search with compliance built in.

  • Market intelligence

    Unified global research with precision search and built-in compliance for faster decisions.

  • Research compliance

    Automated adherence workflows across 13 countries.

Common questions

Questions life sciences teams ask.

Scientific literature, preprints, conference abstracts, patents, trial registries, regulatory updates and competitor pipeline intelligence, alongside your internal research, unified in one governed platform and cited to the source document.

Yes. Industry-specific enrichment lets a therapeutic team scope answers to the literature and signals that matter to them, tagged to mechanisms and indications.

Yes: governed AI on permissioned content, SOC 2, zero data retention, and no training on your content, with every answer traceable to its source document.

Related

See it on your therapeutic-area questions.

Bring a real question, and we’ll show you a sourced answer you can act on.

Book a live demo